Cannabinoid Receptor Type 2 Agonist, GW405833, Reduced the Impacts of MDA-MB-231 Breast Cancer Cells on Bone Cells.

Cancer Med · 2025 · PMC11842928 · PMID 39980332

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Even though the result was not statistically significant, OPG/RANKL showed an increasing trend in the presence of GW405833 even under the exposure of MDA‐MB‐231 CM (Figure 7F ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.